Hopp til innhold
NHI.no
Annonse

Hva kan du gjøre selv?

  • Vanligvis er tiltak eller behandling unødvendig
  • Føler du deg frisk og væskingen alltid kommer etter en eller annen form for stimulering av brystene eller brystvortene, behøver du ikke bekymre deg for tilstanden
  • Nyfødte med væsking fra brystene krever ingen tiltak. Det er en forbigående tilstand. Hos barn som ammes, kan fenomenet vedvare litt lengre enn hos barn som ikke ammes
Annonse

Dette dokumentet er basert på det profesjonelle dokumentet Sekresjon fra brystvorte . Referanselisten for dette dokumentet vises nedenfor

  1. Huang W, Molitch ME. Evaluation and management of galactorrhea. Am Fam Physician. 2012 Jun 1;85(11):1073-80. PMID: 22962879. PubMed
  2. Golshan M. Nipple discharge. UpToDate, last updated Apr 08, 2020. www.uptodate.com
  3. Hussain AN, Policarpio C, Vincent MT. Evaluating nipple discharge. Obstet Gynecol Surv 2006; 61:278. PubMed
  4. Santen RJ, Mansel R. Benign breast disorders. N Engl J Med. 2005;353(3):275–285. PMID: 16034013. PubMed
  5. Molitch ME. Drugs and prolactin. Pituitary. 2008;11(2):209–218. PMID: 18404390. PubMed
  6. Coker F, Taylor D. Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management. CNS Drugs. 2010;24(7):563–574.
  7. Johnsen E, Kroken RA, Wentzel-Larsen T, Jørgensen HA. Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. BMC Psychiatry. 2010;10:26. PubMed
  8. Biller BM. Hyperprolactinemia. Int J Fertil Womens Med 1999; 44: 74-7. PubMed
  9. Alikasifoglu A, Kandemir N, Akalan N, Yordam N. Pituitary adenoma associated with gigantism and hyperprolactinemia. Pediatr Neurosurg 2001; 35: 325-8. PubMed
  10. Raber W, Gessl A, Nowotny P, Vierhapper H. Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin Endocrinol Oxf 2003; 58: 185-91. PubMed
  11. Serri O, Chik CL, Ur E, Ezzat S. Diagnosis and management of hyperprolactinemia. CMAJ 2003; 169: 575-81. Canadian Medical Association Journal
  12. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–288. PMID: 21296991. PubMed
  13. Waaijer L, Simons JM, Borel Rinkes IH, et al. Systematic review and meta-analysis of the diagnostic accuracy of ductoscopy in patients with pathological nipple discharge. Br J Surg 2016. doi:10.1002/bjs.10125 DOI
  14. De Luis DA, Becerra A, Lahera M, Botella JI, Valero MA, Varela C. A randomized cross-over study comparing cabergoline and quinagolide in the treatment of hyperprolactinemic patients. J Endocrinol Invest 2000; 23: 428-34. PubMed
Annonse
Annonse